Oziel Pharmaceuticals Private Limited, a active private limited company, was established on 03 June 2015 in Noida, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U85191UP2015PTC071100. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 66 professional, Its leadership includes Kamal Kishore Singh (Director), Manish Mishra (Director), Mayank Chaubey (Director). It holds ₹1.30 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Pk 75 Sector 122, Noida, Uttar Pradesh, 201301.
U85191UP2015PTC071100
071100
03 June 2015
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Oziel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Kishore Singh | Director | 03 Jun 2015 | Current |
| Manish Mishra | Director | 03 Jun 2015 | Current |
| Mayank Chaubey | Director | 03 Jun 2015 | Current |
| Vamsi Vijjapu | Director | 03 Jun 2015 | Current |
| Ritesh Kumar Gupta | Director | 03 Jun 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oziel Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 2.04% increase. The company also saw a slight improvement in profitability, with a 3.15% increase in profit. The company's net worth Soared by an impressive increase of 235.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Oziel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,965,394.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Dec 2023 | Hdfc Bank Limited | ₹1.40 M | Open |
| 18 Jan 2023 | Hdfc Bank Limited | ₹1.45 M | Open |
| 08 Nov 2022 | Hdfc Bank Limited | ₹1.80 M | Open |
| 25 Jul 2022 | Hdfc Bank Limited | ₹5.00 M | Open |
| 31 Jan 2022 | Hdfc Bank Limited | ₹1.10 M | Open |
Explore comprehensive loan charge details -
Oziel Pharmaceuticals has a workforce of 66 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oziel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oziel Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Oziel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Oziel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 1.40 M with Charge ID 100839162 was registered on 18 Dec 2023. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 1.45 M with Charge ID 100685495 was registered on 18 Jan 2023. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 1.80 M with Charge ID 100679028 was registered on 08 Nov 2022. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 5.00 M with Charge ID 100678821 was registered on 25 Jul 2022. was documented.
The CIN of Oziel Pharmaceuticals Private Limited is U85191UP2015PTC071100.
Oziel Pharmaceuticals Private Limited is headquartered at Pk 75 Sector 122, Noida, Uttar Pradesh, 201301.
Oziel Pharmaceuticals Private Limited was incorporated on 03 June 2015.
The current directors of Oziel Pharmaceuticals Private Limited are
The primary industry of Oziel Pharmaceuticals Private Limited is Manufacturing.
Oziel Pharmaceuticals Private Limited is unlisted.
The authorized capital of Oziel Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Oziel Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX